IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion
IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today released its annual U.S. Pharmaceutical Market Performance ReviewTM, reporting that overall sales growth in the U.S. prescription market moderated to 3.8 percent in 2007, compared with growth of more than 8 percent in 2006. Total U.S. prescription sales reached $286.5 billion, with slower sales growth resulting from loss of exclusivity of branded medicines, fewer new product approvals, the levelling of year-over-year growth from the Medicare Part D program, and the impact of safety issues.
